What is NDC 0143-9564?

0143-9564 is the product NDC for Phentolamine Mesylate, Phentolamine mesylate 5 mg/mL injection, powder, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Phentolamine Mesylate?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Phentolamine Mesylate NDC 0143-9564

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9564Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9564Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9564-01	0014395640100143956401	1 VIAL in 1 BOX (0143-9564-01) / 1 mL in 1 VIALMarketed from Nov 4, 2015
0143-9564-10	0014395641000143956410	10 VIAL in 1 BOX (0143-9564-10) / 1 mL in 1 VIALMarketed from Nov 4, 2015

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phentolamine Mesylate
Generic name (nonproprietary): phentolamine mesylate
Active ingredients: Phentolamine mesylate — 5 mg/mL
Dosage form: Injection, Powder, For solution
Route: Intramuscular, Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040235
Marketing start: May 15, 1998
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 0143-9564_264ee71e-7e33-4693-b993-8ee0cc2f8d48SPL ID 264ee71e-7e33-4693-b993-8ee0cc2f8d48SPL set ID ed6c506c-5535-4b7c-ae1a-d63f09d796c9RxCUI 1361023UNII Y7543E5K9T
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143956401 followed by a unit qualifier and the quantity

Package 00143-9564-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 13, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Phentolamine Mesylate for Injection is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. Phentolamine Mesylate for Injection is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. Phentolamine Mesylate for Injection is also indicated for the diagnosis of pheochromocytoma by the phentolamine blocking test.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9564

What is NDC 0143-9564?: 0143-9564 is the product NDC for Phentolamine Mesylate, Phentolamine mesylate 5 mg/mL injection, powder, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Phentolamine Mesylate.
What is the active ingredient?: Phentolamine mesylate.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Phentolamine Mesylate?: 1 other product NDC are listed under this name. See all Phentolamine Mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Phentolamine Mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Phentolamine Mesylate	Phentolamine mesylate 5 mg/1	InjectionIntramuscular, Intravenous	Precision Dose Inc.	68094-101	68094-0101-20